Cargando…
Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors
BACKGROUND: Tertiary lymphoid structures (TLSs) are ectopic lymphoid aggregates in non-lymphoid tissues, which are associated with improved prognosis in some cancer types. This study aimed to investigate the clinical significance of TLSs in oesophageal cancer (EC). METHODS: In a series of 316 EC sur...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241865/ https://www.ncbi.nlm.nih.gov/pubmed/37016103 http://dx.doi.org/10.1038/s41416-023-02235-9 |
_version_ | 1785054084417454080 |
---|---|
author | Hayashi, Yoshinori Makino, Tomoki Sato, Eiichi Ohshima, Kenji Nogi, Yuya Kanemura, Takashi Honma, Keiichiro Yamashita, Kotaro Saito, Takuro Tanaka, Koji Yamamoto, Kazuyoshi Takahashi, Tsuyoshi Kurokawa, Yukinori Miyata, Hiroshi Nakajima, Kiyokazu Wada, Hisashi Morii, Eiichi Eguchi, Hidetoshi Doki, Yuichiro |
author_facet | Hayashi, Yoshinori Makino, Tomoki Sato, Eiichi Ohshima, Kenji Nogi, Yuya Kanemura, Takashi Honma, Keiichiro Yamashita, Kotaro Saito, Takuro Tanaka, Koji Yamamoto, Kazuyoshi Takahashi, Tsuyoshi Kurokawa, Yukinori Miyata, Hiroshi Nakajima, Kiyokazu Wada, Hisashi Morii, Eiichi Eguchi, Hidetoshi Doki, Yuichiro |
author_sort | Hayashi, Yoshinori |
collection | PubMed |
description | BACKGROUND: Tertiary lymphoid structures (TLSs) are ectopic lymphoid aggregates in non-lymphoid tissues, which are associated with improved prognosis in some cancer types. This study aimed to investigate the clinical significance of TLSs in oesophageal cancer (EC). METHODS: In a series of 316 EC surgical specimens from two different institutes, we evaluated the density and maturity of peritumoral TLSs using haematoxylin/eosin, immunohistochemistry, and multiplex immunofluorescence staining. We analysed the association between TLSs and clinicopathological parameters. The clinical significance of TLSs was further evaluated in a different cohort of 34 patients with recurrent EC treated with anti-PD-1 antibody. RESULTS: Tumours with high TLS density predominantly consisted of matured TLSs. High TLS density was significantly associated with less advanced tumour stage, absence of lymphatic/vascular invasion, better serum nutrition parameters (neutrophils count, albumin, neutrophil-to-lymphocyte ratio, and prognostic nutritional index), and prolonged survival. This survival trend was more remarkable in cases with matured TLSs, which represented an increased population of CD138(+) plasma cells. In the second EC cohort, TLS density predicted the clinical response to anti-PD-1 antibody and patient survival. CONCLUSION: The density and maturity of peritumoral TLSs are useful parameters for predicting long-term survival and response to anti-PD-1 antibody treatment in EC patients. |
format | Online Article Text |
id | pubmed-10241865 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-102418652023-06-07 Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors Hayashi, Yoshinori Makino, Tomoki Sato, Eiichi Ohshima, Kenji Nogi, Yuya Kanemura, Takashi Honma, Keiichiro Yamashita, Kotaro Saito, Takuro Tanaka, Koji Yamamoto, Kazuyoshi Takahashi, Tsuyoshi Kurokawa, Yukinori Miyata, Hiroshi Nakajima, Kiyokazu Wada, Hisashi Morii, Eiichi Eguchi, Hidetoshi Doki, Yuichiro Br J Cancer Article BACKGROUND: Tertiary lymphoid structures (TLSs) are ectopic lymphoid aggregates in non-lymphoid tissues, which are associated with improved prognosis in some cancer types. This study aimed to investigate the clinical significance of TLSs in oesophageal cancer (EC). METHODS: In a series of 316 EC surgical specimens from two different institutes, we evaluated the density and maturity of peritumoral TLSs using haematoxylin/eosin, immunohistochemistry, and multiplex immunofluorescence staining. We analysed the association between TLSs and clinicopathological parameters. The clinical significance of TLSs was further evaluated in a different cohort of 34 patients with recurrent EC treated with anti-PD-1 antibody. RESULTS: Tumours with high TLS density predominantly consisted of matured TLSs. High TLS density was significantly associated with less advanced tumour stage, absence of lymphatic/vascular invasion, better serum nutrition parameters (neutrophils count, albumin, neutrophil-to-lymphocyte ratio, and prognostic nutritional index), and prolonged survival. This survival trend was more remarkable in cases with matured TLSs, which represented an increased population of CD138(+) plasma cells. In the second EC cohort, TLS density predicted the clinical response to anti-PD-1 antibody and patient survival. CONCLUSION: The density and maturity of peritumoral TLSs are useful parameters for predicting long-term survival and response to anti-PD-1 antibody treatment in EC patients. Nature Publishing Group UK 2023-04-04 2023-06-29 /pmc/articles/PMC10241865/ /pubmed/37016103 http://dx.doi.org/10.1038/s41416-023-02235-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Hayashi, Yoshinori Makino, Tomoki Sato, Eiichi Ohshima, Kenji Nogi, Yuya Kanemura, Takashi Honma, Keiichiro Yamashita, Kotaro Saito, Takuro Tanaka, Koji Yamamoto, Kazuyoshi Takahashi, Tsuyoshi Kurokawa, Yukinori Miyata, Hiroshi Nakajima, Kiyokazu Wada, Hisashi Morii, Eiichi Eguchi, Hidetoshi Doki, Yuichiro Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors |
title | Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors |
title_full | Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors |
title_fullStr | Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors |
title_full_unstemmed | Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors |
title_short | Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors |
title_sort | density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241865/ https://www.ncbi.nlm.nih.gov/pubmed/37016103 http://dx.doi.org/10.1038/s41416-023-02235-9 |
work_keys_str_mv | AT hayashiyoshinori densityandmaturityofperitumoraltertiarylymphoidstructuresinoesophagealsquamouscellcarcinomapredictspatientsurvivalandresponsetoimmunecheckpointinhibitors AT makinotomoki densityandmaturityofperitumoraltertiarylymphoidstructuresinoesophagealsquamouscellcarcinomapredictspatientsurvivalandresponsetoimmunecheckpointinhibitors AT satoeiichi densityandmaturityofperitumoraltertiarylymphoidstructuresinoesophagealsquamouscellcarcinomapredictspatientsurvivalandresponsetoimmunecheckpointinhibitors AT ohshimakenji densityandmaturityofperitumoraltertiarylymphoidstructuresinoesophagealsquamouscellcarcinomapredictspatientsurvivalandresponsetoimmunecheckpointinhibitors AT nogiyuya densityandmaturityofperitumoraltertiarylymphoidstructuresinoesophagealsquamouscellcarcinomapredictspatientsurvivalandresponsetoimmunecheckpointinhibitors AT kanemuratakashi densityandmaturityofperitumoraltertiarylymphoidstructuresinoesophagealsquamouscellcarcinomapredictspatientsurvivalandresponsetoimmunecheckpointinhibitors AT honmakeiichiro densityandmaturityofperitumoraltertiarylymphoidstructuresinoesophagealsquamouscellcarcinomapredictspatientsurvivalandresponsetoimmunecheckpointinhibitors AT yamashitakotaro densityandmaturityofperitumoraltertiarylymphoidstructuresinoesophagealsquamouscellcarcinomapredictspatientsurvivalandresponsetoimmunecheckpointinhibitors AT saitotakuro densityandmaturityofperitumoraltertiarylymphoidstructuresinoesophagealsquamouscellcarcinomapredictspatientsurvivalandresponsetoimmunecheckpointinhibitors AT tanakakoji densityandmaturityofperitumoraltertiarylymphoidstructuresinoesophagealsquamouscellcarcinomapredictspatientsurvivalandresponsetoimmunecheckpointinhibitors AT yamamotokazuyoshi densityandmaturityofperitumoraltertiarylymphoidstructuresinoesophagealsquamouscellcarcinomapredictspatientsurvivalandresponsetoimmunecheckpointinhibitors AT takahashitsuyoshi densityandmaturityofperitumoraltertiarylymphoidstructuresinoesophagealsquamouscellcarcinomapredictspatientsurvivalandresponsetoimmunecheckpointinhibitors AT kurokawayukinori densityandmaturityofperitumoraltertiarylymphoidstructuresinoesophagealsquamouscellcarcinomapredictspatientsurvivalandresponsetoimmunecheckpointinhibitors AT miyatahiroshi densityandmaturityofperitumoraltertiarylymphoidstructuresinoesophagealsquamouscellcarcinomapredictspatientsurvivalandresponsetoimmunecheckpointinhibitors AT nakajimakiyokazu densityandmaturityofperitumoraltertiarylymphoidstructuresinoesophagealsquamouscellcarcinomapredictspatientsurvivalandresponsetoimmunecheckpointinhibitors AT wadahisashi densityandmaturityofperitumoraltertiarylymphoidstructuresinoesophagealsquamouscellcarcinomapredictspatientsurvivalandresponsetoimmunecheckpointinhibitors AT moriieiichi densityandmaturityofperitumoraltertiarylymphoidstructuresinoesophagealsquamouscellcarcinomapredictspatientsurvivalandresponsetoimmunecheckpointinhibitors AT eguchihidetoshi densityandmaturityofperitumoraltertiarylymphoidstructuresinoesophagealsquamouscellcarcinomapredictspatientsurvivalandresponsetoimmunecheckpointinhibitors AT dokiyuichiro densityandmaturityofperitumoraltertiarylymphoidstructuresinoesophagealsquamouscellcarcinomapredictspatientsurvivalandresponsetoimmunecheckpointinhibitors |